These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 32147964)

  • 1. Impact of Medicaid expansion on access and healthcare among individuals with sickle cell disease.
    Kayle M; Valle J; Paulukonis S; Holl JL; Tanabe P; French DD; Garg R; Liem RI; Badawy SM; Treadwell MJ
    Pediatr Blood Cancer; 2020 May; 67(5):e28152. PubMed ID: 32147964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.
    Valle J; Lebensburger JD; Garimella PS; Gopal S
    JMIR Public Health Surveill; 2024 Jul; 10():e57290. PubMed ID: 39008353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children.
    Brousseau DC; Richardson T; Hall M; Ellison AM; Shah SS; Raphael JL; Bundy DG; Arnold S
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31227564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease.
    Kang HA; Barner JC
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1412-1422. PubMed ID: 33119448
    [No Abstract]   [Full Text] [Related]  

  • 5. Sickle-cell disease in California: a population-based description of emergency department utilization.
    Wolfson JA; Schrager SM; Coates TD; Kipke MD
    Pediatr Blood Cancer; 2011 Mar; 56(3):413-9. PubMed ID: 21225920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use.
    Crego N; Douglas C; Bonnabeau E; Earls M; Eason K; Merwin E; Rains G; Tanabe P; Shah N
    J Am Board Fam Med; 2020; 33(1):91-105. PubMed ID: 31907250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country.
    Lobo C; Moura P; Fidlarczyk D; Duran J; Barbosa R; Oliveira T; do Nascimento EM; Bhakta N; Hankins JS
    BMC Health Serv Res; 2022 Jan; 22(1):42. PubMed ID: 34998394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affordable Care Act and healthcare delivery: A comparison of California and Florida hospitals and emergency departments.
    Barakat MT; Mithal A; Huang RJ; Mithal A; Sehgal A; Banerjee S; Singh G
    PLoS One; 2017; 12(8):e0182346. PubMed ID: 28771602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency department utilization by Californians with sickle cell disease, 2005-2014.
    Paulukonis ST; Feuchtbaum LB; Coates TD; Neumayr LD; Treadwell MJ; Vichinsky EP; Hulihan MM
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 28000344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sickle cell disease in California: sociodemographic predictors of emergency department utilization.
    Wolfson JA; Schrager SM; Khanna R; Coates TD; Kipke MD
    Pediatr Blood Cancer; 2012 Jan; 58(1):66-73. PubMed ID: 21360655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea Initiation Among Children With Sickle Cell Anemia.
    Reeves SL; Jary HK; Gondhi JP; Raphael JL; Lisabeth LD; Dombkowski KJ
    Clin Pediatr (Phila); 2019 Nov; 58(13):1394-1400. PubMed ID: 31113236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Trends and the Impact of the Affordable Care Act on Emergency Department Visits and Hospitalizations for Gastrointestinal, Pancreatic, and Liver Diseases.
    Barakat MT; Mithal A; Huang RJ; Sehgal A; Sehgal A; Singh G; Banerjee S
    J Clin Gastroenterol; 2020 Mar; 54(3):e21-e29. PubMed ID: 30285976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease.
    Attell BK; Plaxco AP; Zhou M; Valle J; Reeves SL; Patel PN; Latta K; Smeltzer MP; Snyder AB
    BMC Emerg Med; 2024 Jul; 24(1):134. PubMed ID: 39075379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related prescription medication utilization for the -management of sickle cell disease among Texas Medicaid patients.
    Shukla N; Barner JC; Lawson KA; Rascati KL
    J Opioid Manag; 2021; 17(4):301-310. PubMed ID: 34533824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
    Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
    Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017.
    Su ZT; Segal JB; Lanzkron S; Ogunsile FJ
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1246-1250. PubMed ID: 31328369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics.
    Rushing M; Horiuchi S; Zhou M; Kavanagh PL; Reeves SL; Snyder A; Paulukonis S
    Pediatr Blood Cancer; 2024 Oct; 71(10):e31188. PubMed ID: 39010280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.
    Shatin D; Levin R; Ireys HT; Haller V
    Pediatrics; 1998 Oct; 102(4):E44. PubMed ID: 9755281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.
    Lanzkron S; Carroll CP; Haywood C
    Am J Hematol; 2010 Oct; 85(10):797-9. PubMed ID: 20730795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease.
    Blinder MA; Duh MS; Sasane M; Trahey A; Paley C; Vekeman F
    J Emerg Med; 2015 Oct; 49(4):513-522.e1. PubMed ID: 25910824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.